Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutamide and Testolactone in CAH
NCT00001521Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 1995
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of flutamide and testolactone in congenital adrenal hyperplasia (CAH) (2 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Adult Height Relative to General Population at 11 years. Started Jun 1995; status: completed.
02
Drugs
flutamidetestolactone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT00001521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001521.